• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

青紫型先天性心脏病患儿血栓素A2和前列环素生物合成异常。

Abnormalities in the biosynthesis of thromboxane A2 and prostacyclin in children with cyanotic congenital heart disease.

作者信息

Adatia I, Barrow S E, Stratton P, Ritter J M, Haworth S G

机构信息

Department of Developmental Vascular Biology and Pharmacology, Institute of Child Health, London.

出版信息

Br Heart J. 1993 Feb;69(2):179-82. doi: 10.1136/hrt.69.2.179.

DOI:10.1136/hrt.69.2.179
PMID:8435245
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1024947/
Abstract

BACKGROUND

Children with cyanotic congenital heart disease and pulmonary outflow tract obstruction have shortened platelet survival times and are susceptible to thrombosis and organ infarction. Thromboxane A2 and prostacyclin have opposing actions on platelet aggregability and an imbalance in their biosynthesis might contribute to the pathophysiology of these complications.

METHODS

Biosynthesis of thromboxane A2 and prostacyclin was investigated in 16 children (4-32 months, median 18 months) with cyanotic congenital heart disease and pulmonary outflow tract obstruction and compared with 16 healthy children of a similar age (6-34 months, median 24 months). Urinary excretion of 2,3-dinor-thromboxane B2 (a metabolite of thromboxane A2) and of 2,3-dinor-6-oxo-prostaglandin F1 alpha (a metabolite of prostacyclin) was measured.

RESULTS

The children with cyanotic congenital heart disease and pulmonary outflow tract obstruction excreted more 2,3-dinor-thromboxane B2 than the healthy children: 916(163) compared with 592(122) ng/g creatinine (mean(SEM); 2p = 0.014). The ratio of excretion of 2,3-dinor-thromboxane B2 to 2,3-dinor-prostaglandin F1 alpha was greater in the patients than in the healthy control group (2.38(0.28) v 1.3(0.22)) (2p = 0.002).

CONCLUSION

The balance between biosynthesis of prostacyclin and of thromboxane A2 is abnormal in children with cyanotic congenital heart disease and pulmonary outflow tract obstruction and favours platelet aggregation and vasoconstriction.

摘要

背景

患有青紫型先天性心脏病和肺流出道梗阻的儿童血小板存活时间缩短,易发生血栓形成和器官梗死。血栓素A2和前列环素对血小板聚集性有相反作用,其生物合成失衡可能导致这些并发症的病理生理过程。

方法

对16名患有青紫型先天性心脏病和肺流出道梗阻的儿童(4 - 32个月,中位年龄18个月)的血栓素A2和前列环素生物合成进行研究,并与16名年龄相仿的健康儿童(6 - 34个月,中位年龄24个月)作比较。测量尿中2,3 - 二去甲血栓素B2(血栓素A2的一种代谢产物)和2,3 - 二去甲 - 6 - 氧代前列腺素F1α(前列环素的一种代谢产物)的排泄量。

结果

患有青紫型先天性心脏病和肺流出道梗阻的儿童排泄的2,3 - 二去甲血栓素B2比健康儿童多:分别为916(163) ng/g肌酐和592(122) ng/g肌酐(均值(标准误);P = 0.014)。患者中2,3 - 二去甲血栓素B2与2,3 - 二去甲前列腺素F1α的排泄比值高于健康对照组(2.38(0.28) 对1.3(0.22))(P = 0.002)。

结论

患有青紫型先天性心脏病和肺流出道梗阻的儿童,前列环素和血栓素A2的生物合成平衡异常,有利于血小板聚集和血管收缩。

相似文献

1
Abnormalities in the biosynthesis of thromboxane A2 and prostacyclin in children with cyanotic congenital heart disease.青紫型先天性心脏病患儿血栓素A2和前列环素生物合成异常。
Br Heart J. 1993 Feb;69(2):179-82. doi: 10.1136/hrt.69.2.179.
2
Thromboxane A2 and prostacyclin biosynthesis in children and adolescents with pulmonary vascular disease.
Circulation. 1993 Nov;88(5 Pt 1):2117-22. doi: 10.1161/01.cir.88.5.2117.
3
Effect of intracardiac repair on biosynthesis of thromboxane A2 and prostacyclin in children with a left to right shunt.心内修复对左向右分流型儿童血栓素A2和前列环素生物合成的影响。
Br Heart J. 1994 Nov;72(5):452-6. doi: 10.1136/hrt.72.5.452.
4
Chronic effects of oral prostacyclin analogue on thromboxane A2 and prostacyclin metabolites in pulmonary hypertension.口服前列环素类似物对肺动脉高压中血栓素A2和前列环素代谢产物的慢性影响。
Acta Paediatr Jpn. 1998 Feb;40(1):14-9. doi: 10.1111/j.1442-200x.1998.tb01395.x.
5
Mechanisms underlying early development of pulmonary vascular obstructive disease in Down syndrome: An imbalance in biosynthesis of thromboxane A2 and prostacyclin.唐氏综合征肺血管阻塞性疾病早期发病机制:血栓素 A2 和前列环素生物合成失衡。
Am J Med Genet A. 2010 Aug;152A(8):1919-24. doi: 10.1002/ajmg.a.33555.
6
Biosynthesis of prostacyclin and thromboxane A2 during chronic hypoxaemia in children with cyanotic congenital heart disease.患青紫型先天性心脏病儿童慢性低氧血症期间前列环素和血栓素A2的生物合成
Eur J Clin Invest. 1996 Dec;26(12):1057-61. doi: 10.1046/j.1365-2362.1996.370590.x.
7
Renal prostacyclin and thromboxane in normotensive and preeclamptic pregnant women and their infants.正常血压和先兆子痫孕妇及其婴儿体内的肾前列环素和血栓素
J Clin Endocrinol Metab. 1986 Dec;63(6):1307-12. doi: 10.1210/jcem-63-6-1307.
8
Endogenous formation of prostanoids in neonates with persistent pulmonary hypertension.持续性肺动脉高压新生儿体内前列腺素的内源性生成
Arch Dis Child. 1989 Jul;64(7 Spec No):949-52. doi: 10.1136/adc.64.7_spec_no.949.
9
An imbalance between the excretion of thromboxane and prostacyclin metabolites in women after the menopause.绝经后女性血栓素和前列环素代谢产物排泄之间的失衡。
Zentralbl Gynakol. 1993;115(4):163-6.
10
An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension.肺动脉高压中血栓素与前列环素代谢产物排泄之间的失衡。
N Engl J Med. 1992 Jul 9;327(2):70-5. doi: 10.1056/NEJM199207093270202.

引用本文的文献

1
Inflammatory cytokines, apoptotic, tissue injury and remodeling biomarkers in children with congenital heart disease.先天性心脏病患儿的炎性细胞因子、凋亡、组织损伤及重塑生物标志物
Indian J Clin Biochem. 2014 Apr;29(2):145-9. doi: 10.1007/s12291-013-0341-0. Epub 2013 May 23.
2
Furegrelate, a thromboxane synthase inhibitor, blunts the development of pulmonary arterial hypertension in neonatal piglets.非诺贝特,一种血栓素合酶抑制剂,可抑制新生仔猪肺动脉高压的发展。
Pulm Circ. 2012 Apr-Jun;2(2):193-200. doi: 10.4103/2045-8932.97605.
3
Pulmonary arterial hypertension: a comparison between children and adults.肺动脉高压:儿童与成人的比较。
Eur Respir J. 2011 Mar;37(3):665-77. doi: 10.1183/09031936.00056110.
4
Aspirin resistance in children with heart disease at risk for thromboembolism: prevalence and possible mechanisms.有血栓栓塞风险的心脏病患儿的阿司匹林抵抗:患病率及可能机制
Pediatr Cardiol. 2008 Mar;29(2):285-91. doi: 10.1007/s00246-007-9098-7. Epub 2007 Sep 25.
5
Children undergoing cardiac surgery for complex cardiac defects show imbalance between pro- and anti-thrombotic activity.因复杂心脏缺陷接受心脏手术的儿童表现出促血栓形成和抗血栓形成活性之间的失衡。
Crit Care. 2006;10(6):R165. doi: 10.1186/cc5108.

本文引用的文献

1
Pulmonary thrombosis in cyanotic congenital heart disease without pulmonary hypertension.无肺动脉高压的青紫型先天性心脏病中的肺血栓形成
J Pathol Bacteriol. 1958 Apr;75(2):281-91. doi: 10.1002/path.1700750206.
2
Growth and development of pulmonary circulation in pulmonary atresia with ventricular septal defect and major aortopulmonary collateral arteries.室间隔缺损合并主-肺动脉侧支动脉的肺动脉闭锁患者肺循环的生长与发育
Br Heart J. 1980 Jul;44(1):14-24. doi: 10.1136/hrt.44.1.14.
3
Pulmonary vascular and alveolar development in tetralogy of Fallot: a recommendation for early correction.法洛四联症的肺血管和肺泡发育:早期矫正的建议
Thorax. 1982 Dec;37(12):893-901. doi: 10.1136/thx.37.12.893.
4
Estimated rate of prostacyclin secretion into the circulation of normal man.正常男性循环系统中前列环素分泌的估计速率。
J Clin Invest. 1981 Nov;68(5):1272-6. doi: 10.1172/jci110373.
5
Bovine endothelial cells in culture produce thromboxane as well as prostacyclin.培养中的牛内皮细胞会产生血栓素和前列环素。
J Clin Invest. 1981 May;67(5):1292-6. doi: 10.1172/jci110157.
6
Metabolism of prostacyclin and 6-keto-prostaglandin F1 alpha in man.人前列腺素I2和6-酮-前列腺素F1α的代谢
J Biol Chem. 1980 Nov 10;255(21):10194-8.
7
Myocardial infarction as a manifestation of polycythemia in cyanotic heart disease.
Am J Cardiol. 1984 Mar 15;53(7):952-3. doi: 10.1016/0002-9149(84)90532-0.
8
Effects of hyperoxia and hypoxia on vascular prostacyclin formation in vitro.
Pediatrics. 1984 Oct;74(4):548-53.
9
Synthesis of leukotriene B4, and prostanoids by human alveolar macrophages: analysis by gas chromatography/mass spectrometry.
Prostaglandins. 1984 Feb;27(2):163-79. doi: 10.1016/0090-6980(84)90071-6.
10
The platelets in cyanotic congenital heart disease.青紫型先天性心脏病中的血小板。
Pediatrics. 1968 Oct;42(4):651-8.